▶ 調査レポート

ペット用治療薬の世界市場2020年:企業別、地域別、種類・用途別

• 英文タイトル:Global Pet Pain Management Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ペット用治療薬の世界市場2020年:企業別、地域別、種類・用途別 / Global Pet Pain Management Drugs Market 2020 by Company, Regions, Type and Application, Forecast to 2025 / MRC2012B0988資料のイメージです。• レポートコード:MRC2012B0988
• 出版社/出版日:GlobalInfoResearch / 2020年12月24日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、103ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ペット用治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。ペット用治療薬の種類別市場規模(NSAID、オピオイド、局所麻酔薬、アルファ2アゴニスト、疾患修飾性変形性関節症薬、その他薬剤)、用途別市場規模(犬、猫、馬、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。
・市場概要
・企業情報(販売量、市場シェア、製品概要、SWOT分析):Boehringer Ingelheim、Dechra Pharmaceuticals、Bayer、Zoetis、Ceva Sante Animale、Merck Animal Health、Norbrook Laboratories、Vetoquinol、Chanelle、
・地域別グローバル市場分析 2015年-2020年
・ペット用治療薬の北米市場(アメリカ、カナダ、メキシコ)
・ペット用治療薬のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ペット用治療薬のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ペット用治療薬の南米市場(ブラジル、アルゼンチン)
・ペット用治療薬の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:NSAID、オピオイド、局所麻酔薬、アルファ2アゴニスト、疾患修飾性変形性関節症薬、その他薬剤
・用途別分析:犬、猫、馬、その他
・地域別市場規模予測 2021年-2025年
・調査の結果・結論

Market Overview
The global Pet Pain Management Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Pet Pain Management Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Pet Pain Management Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Pet Pain Management Drugs market has been segmented into:
NSAIDs
Opioids
Local Anesthetics
Alpha-2 Agonists
Disease-modifying Osteoarthritis Agents
Other Drugs

By Application, Pet Pain Management Drugs has been segmented into:
Dogs
Cats
Horses
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Pet Pain Management Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Pet Pain Management Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Pet Pain Management Drugs market.

The report offers in-depth assessment of the growth and other aspects of the Pet Pain Management Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Pet Pain Management Drugs Market Share Analysis
Pet Pain Management Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Pet Pain Management Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Pet Pain Management Drugs sales, revenue and market share for each player covered in this report.

The major players covered in Pet Pain Management Drugs are:
Boehringer Ingelheim
Dechra Pharmaceuticals
Bayer
Zoetis
Ceva Sante Animale
Merck Animal Health
Norbrook Laboratories
Vetoquinol
Chanelle

レポート目次

Table of Contents

1 Pet Pain Management Drugs Market Overview
1.1 Product Overview and Scope of Pet Pain Management Drugs
1.2 Classification of Pet Pain Management Drugs by Type
1.2.1 Global Pet Pain Management Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Pet Pain Management Drugs Revenue Market Share by Type in 2019
1.2.3 NSAIDs
1.2.4 Opioids
1.2.5 Local Anesthetics
1.2.6 Alpha-2 Agonists
1.2.7 Disease-modifying Osteoarthritis Agents
1.2.8 Other Drugs
1.3 Global Pet Pain Management Drugs Market by Application
1.3.1 Overview: Global Pet Pain Management Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Dogs
1.3.3 Cats
1.3.4 Horses
1.3.5 Other
1.4 Global Pet Pain Management Drugs Market by Regions
1.4.1 Global Pet Pain Management Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Pet Pain Management Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Pet Pain Management Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Pet Pain Management Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Pet Pain Management Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Pet Pain Management Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Pet Pain Management Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Dechra Pharmaceuticals
2.2.1 Dechra Pharmaceuticals Details
2.2.2 Dechra Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Dechra Pharmaceuticals SWOT Analysis
2.2.4 Dechra Pharmaceuticals Product and Services
2.2.5 Dechra Pharmaceuticals Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bayer SWOT Analysis
2.3.4 Bayer Product and Services
2.3.5 Bayer Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Zoetis
2.4.1 Zoetis Details
2.4.2 Zoetis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Zoetis SWOT Analysis
2.4.4 Zoetis Product and Services
2.4.5 Zoetis Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 Ceva Sante Animale
2.5.1 Ceva Sante Animale Details
2.5.2 Ceva Sante Animale Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Ceva Sante Animale SWOT Analysis
2.5.4 Ceva Sante Animale Product and Services
2.5.5 Ceva Sante Animale Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck Animal Health
2.6.1 Merck Animal Health Details
2.6.2 Merck Animal Health Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Merck Animal Health SWOT Analysis
2.6.4 Merck Animal Health Product and Services
2.6.5 Merck Animal Health Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Norbrook Laboratories
2.7.1 Norbrook Laboratories Details
2.7.2 Norbrook Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Norbrook Laboratories SWOT Analysis
2.7.4 Norbrook Laboratories Product and Services
2.7.5 Norbrook Laboratories Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Vetoquinol
2.8.1 Vetoquinol Details
2.8.2 Vetoquinol Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Vetoquinol SWOT Analysis
2.8.4 Vetoquinol Product and Services
2.8.5 Vetoquinol Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Chanelle
2.9.1 Chanelle Details
2.9.2 Chanelle Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Chanelle SWOT Analysis
2.9.4 Chanelle Product and Services
2.9.5 Chanelle Pet Pain Management Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Pet Pain Management Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Pet Pain Management Drugs Players Market Share
3.2.2 Top 10 Pet Pain Management Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Pet Pain Management Drugs Revenue and Market Share by Regions
4.2 North America Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.5 South America Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
5 North America Pet Pain Management Drugs Revenue by Countries
5.1 North America Pet Pain Management Drugs Revenue by Countries (2015-2020)
5.2 USA Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
6 Europe Pet Pain Management Drugs Revenue by Countries
6.1 Europe Pet Pain Management Drugs Revenue by Countries (2015-2020)
6.2 Germany Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.3 UK Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.4 France Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Pet Pain Management Drugs Revenue by Countries
7.1 Asia-Pacific Pet Pain Management Drugs Revenue by Countries (2015-2020)
7.2 China Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.5 India Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
8 South America Pet Pain Management Drugs Revenue by Countries
8.1 South America Pet Pain Management Drugs Revenue by Countries (2015-2020)
8.2 Brazil Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Pet Pain Management Drugs by Countries
9.1 Middle East & Africa Pet Pain Management Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Pet Pain Management Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global Pet Pain Management Drugs Market Forecast by Type (2019-2024)
10.3 NSAIDs Revenue Growth Rate (2015-2025)
10.4 Opioids Revenue Growth Rate (2015-2025)
10.5 Local Anesthetics Revenue Growth Rate (2015-2025)
10.6 Alpha-2 Agonists Revenue Growth Rate (2015-2025)
10.7 Disease-modifying Osteoarthritis Agents Revenue Growth Rate (2015-2025)
10.8 Other Drugs Revenue Growth Rate (2015-2025)
11 Global Pet Pain Management Drugs Market Segment by Application
11.1 Global Pet Pain Management Drugs Revenue Market Share by Application (2015-2020)
11.2 Pet Pain Management Drugs Market Forecast by Application (2019-2024)
11.3 Dogs Revenue Growth (2015-2020)
11.4 Cats Revenue Growth (2015-2020)
11.5 Horses Revenue Growth (2015-2020)
11.6 Other Revenue Growth (2015-2020)
12 Global Pet Pain Management Drugs Market Size Forecast (2021-2025)
12.1 Global Pet Pain Management Drugs Market Size Forecast (2021-2025)
12.2 Global Pet Pain Management Drugs Market Forecast by Regions (2021-2025)
12.3 North America Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
12.4 Europe Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
12.6 South America Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables

Table 1. Global Pet Pain Management Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Pet Pain Management Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Pet Pain Management Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Pet Pain Management Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 6. Boehringer Ingelheim Pet Pain Management Drugs Major Business
Table 7. Boehringer Ingelheim Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Boehringer Ingelheim SWOT Analysis
Table 9. Boehringer Ingelheim Pet Pain Management Drugs Product and Solutions
Table 10. Boehringer Ingelheim Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Dechra Pharmaceuticals Corporate Information, Location and Competitors
Table 12. Dechra Pharmaceuticals Pet Pain Management Drugs Major Business
Table 13. Dechra Pharmaceuticals Pet Pain Management Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Dechra Pharmaceuticals SWOT Analysis
Table 15. Dechra Pharmaceuticals Pet Pain Management Drugs Product and Solutions
Table 16. Dechra Pharmaceuticals Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Bayer Corporate Information, Location and Competitors
Table 18. Bayer Pet Pain Management Drugs Major Business
Table 19. Bayer Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Bayer SWOT Analysis
Table 21. Bayer Pet Pain Management Drugs Product and Solutions
Table 22. Bayer Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Zoetis Corporate Information, Location and Competitors
Table 24. Zoetis Pet Pain Management Drugs Major Business
Table 25. Zoetis Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Zoetis SWOT Analysis
Table 27. Zoetis Pet Pain Management Drugs Product and Solutions
Table 28. Zoetis Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Ceva Sante Animale Corporate Information, Location and Competitors
Table 30. Ceva Sante Animale Pet Pain Management Drugs Major Business
Table 31. Ceva Sante Animale Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 32. Ceva Sante Animale SWOT Analysis
Table 33. Ceva Sante Animale Pet Pain Management Drugs Product and Solutions
Table 34. Ceva Sante Animale Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. Merck Animal Health Corporate Information, Location and Competitors
Table 36. Merck Animal Health Pet Pain Management Drugs Major Business
Table 37. Merck Animal Health Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 38. Merck Animal Health SWOT Analysis
Table 39. Merck Animal Health Pet Pain Management Drugs Product and Solutions
Table 40. Merck Animal Health Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Norbrook Laboratories Corporate Information, Location and Competitors
Table 42. Norbrook Laboratories Pet Pain Management Drugs Major Business
Table 43. Norbrook Laboratories Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Norbrook Laboratories SWOT Analysis
Table 45. Norbrook Laboratories Pet Pain Management Drugs Product and Solutions
Table 46. Norbrook Laboratories Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Vetoquinol Corporate Information, Location and Competitors
Table 48. Vetoquinol Pet Pain Management Drugs Major Business
Table 49. Vetoquinol Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Vetoquinol SWOT Analysis
Table 51. Vetoquinol Pet Pain Management Drugs Product and Solutions
Table 52. Vetoquinol Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Chanelle Corporate Information, Location and Competitors
Table 54. Chanelle Pet Pain Management Drugs Major Business
Table 55. Chanelle Pet Pain Management Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Chanelle SWOT Analysis
Table 57. Chanelle Pet Pain Management Drugs Product and Solutions
Table 58. Chanelle Pet Pain Management Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Global Pet Pain Management Drugs Revenue (Million USD) by Players (2015-2020)
Table 60. Global Pet Pain Management Drugs Revenue Share by Players (2015-2020)
Table 61. Global Pet Pain Management Drugs Revenue (Million USD) by Regions (2015-2020)
Table 62. Global Pet Pain Management Drugs Revenue Market Share by Regions (2015-2020)
Table 63. North America Pet Pain Management Drugs Revenue by Countries (2015-2020)
Table 64. North America Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 65. Europe Pet Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 66. Asia-Pacific Pet Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 67. South America Pet Pain Management Drugs Revenue by Countries (2015-2020)
Table 68. South America Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Middle East and Africa Pet Pain Management Drugs Revenue (Million USD) by Countries (2015-2020)
Table 70. Middle East and Africa Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Table 71. Global Pet Pain Management Drugs Revenue (Million USD) by Type (2015-2020)
Table 72. Global Pet Pain Management Drugs Revenue Share by Type (2015-2020)
Table 73. Global Pet Pain Management Drugs Revenue Forecast by Type (2021-2025)
Table 74. Global Pet Pain Management Drugs Revenue by Application (2015-2020)
Table 75. Global Pet Pain Management Drugs Revenue Share by Application (2015-2020)
Table 76. Global Pet Pain Management Drugs Revenue Forecast by Application (2021-2025)
Table 77. Global Pet Pain Management Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Pet Pain Management Drugs Picture
Figure 2. Global Pet Pain Management Drugs Revenue Market Share by Type in 2019
Figure 3. NSAIDs Picture
Figure 4. Opioids Picture
Figure 5. Local Anesthetics Picture
Figure 6. Alpha-2 Agonists Picture
Figure 7. Disease-modifying Osteoarthritis Agents Picture
Figure 8. Other Drugs Picture
Figure 9. Pet Pain Management Drugs Revenue Market Share by Application in 2019
Figure 10. Dogs Picture
Figure 11. Cats Picture
Figure 12. Horses Picture
Figure 13. Other Picture
Figure 14. Global Pet Pain Management Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 15. North America Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Europe Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Asia-Pacific Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. South America Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Middle East and Africa Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 20. Global Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 21. Global Pet Pain Management Drugs Revenue Share by Players in 2019
Figure 22. Global Top 5 Players Pet Pain Management Drugs Revenue Market Share in 2019
Figure 23. Global Top 10 Players Pet Pain Management Drugs Revenue Market Share in 2019
Figure 24. Key Players Market Share Trend
Figure 25. Global Pet Pain Management Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 26. Global Pet Pain Management Drugs Revenue Market Share by Regions (2015-2020)
Figure 27. Global Pet Pain Management Drugs Revenue Market Share by Regions in 2018
Figure 28. North America Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 29. Europe Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Asia-Pacific Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 31. South America Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 32. Middle East and Africa Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 33. North America Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 34. North America Pet Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 35. USA Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Canada Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 37. Mexico Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 38. Europe Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 39. Europe Pet Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 40. Germany Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 41. UK Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 42. France Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Russia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 44. Italy Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 45. Asia-Pacific Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 46. Asia-Pacific Pet Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 47. China Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 48. Japan Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Korea Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 50. India Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 51. Southeast Asia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 52. South America Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 53. South America Pet Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 54. Brazil Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 55. Argentina Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 56. Middle East and Africa Pet Pain Management Drugs Revenue Market Share by Countries (2015-2020)
Figure 57. Middle East and Africa Pet Pain Management Drugs Revenue Market Share by Countries in 2019
Figure 58. Saudi Arabia Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 59. UAE Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Egypt Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 61. South Africa Pet Pain Management Drugs Revenue and Growth Rate (2015-2020)
Figure 62. Global Pet Pain Management Drugs Revenue Share by Type (2015-2020)
Figure 63. Global Pet Pain Management Drugs Revenue Share by Type in 2019
Figure 64. Global Pet Pain Management Drugs Market Share Forecast by Type (2021-2025)
Figure 65. Global NSAIDs Revenue Growth Rate (2015-2020)
Figure 66. Global Opioids Revenue Growth Rate (2015-2020)
Figure 67. Global Local Anesthetics Revenue Growth Rate (2015-2020)
Figure 68. Global Alpha-2 Agonists Revenue Growth Rate (2015-2020)
Figure 69. Global Disease-modifying Osteoarthritis Agents Revenue Growth Rate (2015-2020)
Figure 70. Global Other Drugs Revenue Growth Rate (2015-2020)
Figure 71. Global Pet Pain Management Drugs Revenue Share by Application (2015-2020)
Figure 72. Global Pet Pain Management Drugs Revenue Share by Application in 2019
Figure 73. Global Pet Pain Management Drugs Market Share Forecast by Application (2021-2025)
Figure 74. Global Dogs Revenue Growth Rate (2015-2020)
Figure 75. Global Cats Revenue Growth Rate (2015-2020)
Figure 76. Global Horses Revenue Growth Rate (2015-2020)
Figure 77. Global Other Revenue Growth Rate (2015-2020)
Figure 78. Global Pet Pain Management Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 79. Global Pet Pain Management Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 80. Global Pet Pain Management Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 81. North America Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 82. Europe Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 83. Asia-Pacific Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 84. South America Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 85. Middle East and Africa Pet Pain Management Drugs Revenue Market Forecast (2021-2025)
Figure 86. Sales Channel: Direct Channel vs Indirect Channel